GlassScriptPhysician profile
Derin S Rominger
NPI 1821072760
$5,191.02
in general payments reported to CMS, 2019-2025
36 companies · $203 in 2025
The $203 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $1,353 · 2021: $1,052 · 2022: $771 · 2023: $664 · 2024: $590 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $999.55 | 2019-2025 | Lo Loestrin Fe, Orilissa, Viberzi |
| Medtronic USA, INC. | $903.31 | 2020 | |
| Therapeuticsmd, INC. | $440.25 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $421.42 | 2019-2024 | Xifaxan |
| Astellas Pharma US INC | $405.52 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $298.98 | 2021 | |
| Sumitomo Pharma America, INC. | $289.48 | 2023-2025 | Gemtesa, Myfembree |
| Exeltis, USA INC. | $179.45 | 2020-2024 | Slynd |
| Pfizer INC. | $160.11 | 2023 | |
| Novo Nordisk INC | $130.49 | 2019-2024 | Wegovy |
| Avion Pharmaceuticals | $88.36 | 2021-2022 | |
| Hologic Sales and Service, LLC | $85.48 | 2019-2024 | Aptima |
| Urovant Sciences INC | $83.67 | 2021-2022 | |
| Medtronic, INC. | $82.12 | 2022 | |
| Smith+Nephew, INC. | $67.90 | 2019-2023 | Pico 7 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $59.37 | 2019-2020 | |
| Myovant Sciences INC. | $58.76 | 2022 | |
| Organon LLC | $40.99 | 2021-2023 | Nexplanon |
| Daiichi Sankyo INC. | $34.16 | 2021 | |
| Radius Health, INC. | $33.49 | 2025 | Tymlos |
| Axonics, INC. | $33.42 | 2021-2024 | Axonics |
| Evofem Biosciences, INC. | $27.94 | 2021 | |
| Scynexis, INC. | $27.89 | 2022 | |
| Duchesnay USA Incorporated | $27.85 | 2019 | |
| Merck Sharp & Dohme LLC | $21.37 | 2020 | |
| Coloplast Corp | $20.35 | 2023 | Altis |
| Becton, Dickinson and Company | $19.69 | 2024 | Bd Onclarity |
| Channel Medsystems, INC. | $19.67 | 2022 | |
| Nestle Healthcare Nutrition INC. | $19.50 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.53 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.19 | 2023 | Exparel |
| Sanofi Pasteur INC. | $17.06 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $16.62 | 2025 | |
| Agile Therapeutics, INC. | $15.16 | 2021 | |
| Amgen INC. | $13.28 | 2019 | |
| Allergan, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derin Rominger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.